This is a routine development milestone in the drug approval process. While the brand name selection moves the product closer to market, there is no immediate financial impact. Traders should monitor future regulatory submissions and approval timelines for material updates.
Price Chart
Executive Summary
NutriBand Inc. announced the selection of a commercial worldwide brand name for its lead product, an abuse-deterrent fentanyl transdermal patch, which is currently in development. The company partnered with Brand Institute, Inc. to finalize the name, which will be submitted to the FDA and international regulatory agencies for approval.
Key Facts
- Company selected a commercial brand name for its abuse-deterrent fentanyl transdermal system
- Proposed name will be submitted to FDA and other international regulatory agencies for review and approval
- Name is being submitted for trademark registration in the U.S. and internationally
- Product utilizes NutriBand's AVERSA™ abuse-deterrent technology
- Potential peak annual U.S. sales estimated between $80 million and $200 million
- Company partnered with Brand Institute, Inc. for brand development
Financial Impact
No immediate financial impact; potential peak annual U.S. sales of $80-200 million mentioned as forward-looking estimate
Risk Factors
- Regulatory approval risk for both the product and brand name
- Forward-looking sales estimates may not materialize
- Competition in the fentanyl patch market
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-041006 |
| Document: ea028533001ex99-1.htm | 0001213900-26-041006 |
| Document: 0001213900-26-041006-index-headers.html | 0001213900-26-041006 |
| Document: 0001213900-26-041006-index.html | 0001213900-26-041006 |
| Document: 0001213900-26-041006.txt | 0001213900-26-041006 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 18, 2026 19w ago | 10-K/A | $1.11 $0.3500 | ▼ −68.47% | ▼ −74.76% | $0.5500 (−50.45%) |
Apr 7, 2026 25w ago | 8-K | $1.15 $1.00 | ▼ −13.04% | ▼ −26.31% | $0.5500 (−52.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access